PL2277524T3 - Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia - Google Patents

Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia

Info

Publication number
PL2277524T3
PL2277524T3 PL10182284T PL10182284T PL2277524T3 PL 2277524 T3 PL2277524 T3 PL 2277524T3 PL 10182284 T PL10182284 T PL 10182284T PL 10182284 T PL10182284 T PL 10182284T PL 2277524 T3 PL2277524 T3 PL 2277524T3
Authority
PL
Poland
Prior art keywords
treatment
ibs
effectors
probiotic bacteria
fermented cereal
Prior art date
Application number
PL10182284T
Other languages
English (en)
Inventor
Hans Israelsen
Original Assignee
Nordic Rebalance As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05388079A external-priority patent/EP1769801A1/en
Application filed by Nordic Rebalance As filed Critical Nordic Rebalance As
Publication of PL2277524T3 publication Critical patent/PL2277524T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/152—Cereal germ products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL10182284T 2005-09-28 2006-09-27 Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia PL2277524T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US72127605P 2005-09-28 2005-09-28
EP05388079A EP1769801A1 (en) 2005-09-28 2005-09-28 Use of a fermented cereal composition for the treatment of IBD and IBS
US74471706P 2006-04-12 2006-04-12
DKPA200600529 2006-04-12
EP06776003.3A EP1931363B1 (en) 2005-09-28 2006-09-27 Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors
EP10182284.9A EP2277524B1 (en) 2005-09-28 2006-09-27 Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors

Publications (1)

Publication Number Publication Date
PL2277524T3 true PL2277524T3 (pl) 2016-06-30

Family

ID=43385150

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06776003T PL1931363T3 (pl) 2005-09-28 2006-09-27 Leczenie IBD z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia
PL10182284T PL2277524T3 (pl) 2005-09-28 2006-09-27 Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL06776003T PL1931363T3 (pl) 2005-09-28 2006-09-27 Leczenie IBD z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia

Country Status (10)

Country Link
US (6) US20080311097A1 (pl)
EP (3) EP1931363B1 (pl)
JP (4) JP5363811B2 (pl)
AU (1) AU2006296837B2 (pl)
CA (1) CA2622951A1 (pl)
DK (3) DK2277524T3 (pl)
ES (2) ES2561629T3 (pl)
PL (2) PL1931363T3 (pl)
SI (2) SI2277524T1 (pl)
WO (1) WO2007036230A1 (pl)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1931363B1 (en) * 2005-09-28 2015-11-18 Nordisk Rebalance A/S Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors
ES2395838T3 (es) * 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
FI121912B (fi) 2008-02-05 2011-06-15 Valio Oy Probioottien uusi käyttö
FI20085101L (fi) * 2008-02-05 2009-08-06 Valio Oy Menetelmä ärtyneen suolen oireyhtymän IBS diagnosoimiseksi
US8825503B2 (en) 2008-05-15 2014-09-02 Youdocs, Llc Methods and systems for improving human health using targeted probiotics
NL1036661C2 (en) * 2009-03-04 2010-09-07 Serrix B V Anti-fungal compounds & compositions.
WO2011047153A1 (en) * 2009-10-15 2011-04-21 President And Fellows Of Harvard College Methods for modulating autoimmunity
NZ600258A (en) * 2009-12-22 2014-01-31 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
MX348611B (es) * 2009-12-31 2017-06-21 Milton Trachtman Ira Forma de dosificación oral para usarse en el tratamiento de enfermedad inflamatoria de intestino debido a una infección bacteriana.
WO2011148220A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving transepithelial resistance
WO2011148219A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
TWI392498B (zh) * 2010-07-19 2013-04-11 Synbio Tech Inc 戊糖乳桿菌ｌｐｓ１６及其在抑制幽門螺旋桿菌之用途
US9408878B2 (en) 2010-12-17 2016-08-09 Compagnie Gervais Danone Lactococcus lactis strains for use in improving digestive condition
ES2600963T3 (es) * 2011-06-08 2017-02-13 Novozymes A/S Células/Cepas Lactobacillus secadas por pulverización y su uso contra Helicobacter pylori
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
JP5928774B2 (ja) * 2011-11-01 2016-06-01 株式会社大阪ソーダ β−１，３−グルカンを含む過敏性腸症候群の下痢抑制剤、腹痛改善剤、及び大腸における痛覚過敏改善剤
WO2013072654A1 (en) * 2011-11-16 2013-05-23 Multigerm Uk Enterprises Ltd. Ibs treatment
JP5468183B2 (ja) * 2011-12-28 2014-04-09 株式会社山田養蜂場本社 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途
AU2011385194B2 (en) * 2011-12-29 2015-03-05 Hill's Pet Nutrition, Inc. Compositions and methods for modifying gastrointestinal flora
DE102012002592A1 (de) 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP)
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
DK3628161T3 (da) 2012-11-23 2023-05-30 Seres Therapeutics Inc Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
DE102013100891A1 (de) * 2013-01-29 2014-07-31 Erdinger Weissbräu Franz Brombach e.K. Verfahren zur Herstellung eines Sauergutes, einer Maische oder Würze, eines Getränks, eines Konzentrats sowie die damit hergestellten Erzeugnisse und Verwendung von Milchsäurebakterien, eines Sauerguts, einer Maische, einer Würze oder eines Konzentrats
DE102013008335A1 (de) * 2013-01-29 2014-07-31 Erdinger Weissbräu Franz Brombach e.K. Verfahren zur Herstellung eines Nahrungsmittels sowie das damit hergestellte Nahrungsmittel und Verwendung von Milchsäurebakterien, eines Sauerguts, einer Maische, einer Würze, eines Getränks oder eines Konzentrats
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
AU2014212004B2 (en) 2013-02-04 2018-09-20 Société des Produits Nestlé S.A. Compositions for treating or preventing or reducing the severity of clostridium difficile related diseases
EP2967077A4 (en) 2013-03-15 2016-09-14 Seres Therapeutics Inc NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
CN104208294B (zh) * 2013-09-29 2018-01-16 河南后羿实业集团有限公司 一种用于治疗仔猪黄白痢的中药组合物及其制备方法
KR102611070B1 (ko) 2013-11-25 2023-12-07 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CN104435354A (zh) * 2014-11-21 2015-03-25 王正琦 治疗儿童消化不良的口服液
CN104524006A (zh) * 2014-12-26 2015-04-22 邓小健 健胃消食片及其生产方法
GB201501938D0 (en) * 2015-02-05 2015-03-25 Multigerm Uk Entpr Ltd Probiotic preparation
CN104623145A (zh) * 2015-02-12 2015-05-20 苏州市天灵中药饮片有限公司 一种用于治疗细菌性痢疾的中药提取物及其制备方法
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
PL3341001T3 (pl) * 2015-08-25 2022-07-04 ImmuneBiotech Medical Sweden AB Kompozycja i sposób leczenia i profilaktyki zakażeń i stanu zapalnego jelit
ES3031514T3 (en) * 2015-09-10 2025-07-09 Univ Catholique Louvain Use of pasteurized akkermansia for treating cancer
US11571012B2 (en) 2015-10-26 2023-02-07 CJ Wellcare Corporation Strain derived from traditional fermented food and having excellent enzyme productivity, and method for preparing fermented cereal enzyme food by using same
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
SMT202000547T1 (it) * 2016-02-04 2020-11-10 Univ Gent Uso di comunita' microbiche per la salute umana e animale
JP6329206B2 (ja) * 2016-06-30 2018-05-23 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 消化管フローラを改良する組成物および方法
AU2018255269B2 (en) 2017-04-17 2023-03-09 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
US11273198B2 (en) * 2017-05-04 2022-03-15 Second Genome, Inc. Proteins for the treatment of epithelial barrier function disorders
US11174293B2 (en) 2017-06-02 2021-11-16 Second Genome, Inc. Proteins for the treatment of epithelial barrier function disorders
GB201709763D0 (en) * 2017-06-19 2017-08-02 Probi Ab Biological materials and methods
MX2020001774A (es) 2017-08-14 2020-09-09 Seres Therapeutics Inc Composiciones y métodos para tratar enfermedad colestásica.
US10485253B2 (en) 2017-08-21 2019-11-26 Mustapha Benmoussa Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber
EP3453395B1 (en) * 2017-09-08 2023-10-18 Deutsches Rheuma-Forschungszentrum Berlin Anaeroplasmatales for use in the treatment or prevention of an inflammatory disorder of the digestive system
BR112020008552A2 (pt) 2017-10-30 2020-12-29 Seres Therapeutics, Inc. métodos e composições para tratamento de resistência a antibiótico
JP7215026B2 (ja) * 2018-09-13 2023-01-31 ライオン株式会社 口腔用組成物
CN110624060A (zh) * 2019-07-25 2019-12-31 秦剑 一种治疗幼儿腹泻的中药制剂及其制备方法
CN110452860A (zh) * 2019-09-24 2019-11-15 厦门大学 一种唾液链球菌及其在治疗炎症性肠病药物中的应用
CN110892940A (zh) * 2019-11-20 2020-03-20 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌k56在缓解肠道炎症方面的新应用
TWI777475B (zh) * 2021-03-30 2022-09-11 豐華生物科技股份有限公司 使用乳酸菌菌株組合來治療第1型糖尿病
US20250090606A1 (en) 2022-01-14 2025-03-20 Nordic Rebalance A/S Compositions for treatment of a fatty liver or fibrotic liver disease
WO2024017920A1 (en) 2022-07-18 2024-01-25 Nordic Rebalance A/S Composition comprising fermented cereal gruel
WO2024123266A2 (en) * 2022-12-07 2024-06-13 Yaşar Üni̇versi̇tesi̇ Fermented breakfast cereal base preparation
CN115969957B (zh) * 2022-12-21 2023-07-11 浙江佰穗莱生命健康科技有限公司 一种炎性肠病复合益生菌制剂及其制备方法
CN119096940A (zh) * 2024-08-06 2024-12-10 中山大学附属第三医院 一种鼠乳杆菌诱导小鼠肠易激综合征模型的构建方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
AU624067B2 (en) 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
DK686187D0 (da) 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
SE463796B (sv) 1988-03-09 1991-01-28 Carl Erik Albertsson Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition
EP0414941B1 (de) 1989-08-30 1993-07-28 Siemens Aktiengesellschaft Stellantrieb
WO1991005851A1 (fr) 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus casei subsp casei 37 de production d'une preparation biologique bacterienne
WO1991005850A1 (fr) 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus plantarum 38 de production d'une preparation biologique bacterienne
FI88856C (fi) 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
SE469875C (sv) 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
SE9501056D0 (sv) 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
SE9501719D0 (sv) 1995-05-09 1995-05-09 Probi Ab Pharmaceutical composition
US6303161B1 (en) 1996-04-01 2001-10-16 Nichimo Co., Ltd. Product containing healthful component and process for preparing the same
SE511025C2 (sv) 1997-10-03 1999-07-26 Probi Ab Foderprodukt för häst omfattande Lactobacillus plantarum JI:1 samt Lactobacillus plantarum JI:1 och användning därav
SE523771C2 (sv) 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
EP1276488B1 (en) 2000-03-24 2006-12-20 Societe Des Produits Nestle S.A. Use of lactic acid bacterium for the prevention of peritonitis
SE0003045D0 (sv) * 2000-08-29 2000-08-29 Probi Ab New method
DE10042825A1 (de) 2000-08-30 2002-03-28 New Food Ag Wurst- und Pökelware
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
WO2002086136A1 (en) 2001-04-25 2002-10-31 N.V. Nutricia Process for the manufacture of a fermented health-promoting product
DE10219684A1 (de) * 2001-05-04 2002-11-14 Unternehmensberatung Reichenau Ernährungsprodukt, Pflegeprodukt und Herstellungsverfahren
DE10258129A1 (de) 2002-12-02 2004-06-17 Andrea Reichenauer-Feil Lebensmittelzubereitung
SE526711C2 (sv) 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
SE527555C2 (sv) 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
EP1931363B1 (en) * 2005-09-28 2015-11-18 Nordisk Rebalance A/S Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors

Also Published As

Publication number Publication date
US20130195821A1 (en) 2013-08-01
JP5706461B2 (ja) 2015-04-22
AU2006296837A1 (en) 2007-04-05
EP2277524B1 (en) 2015-11-11
ES2561629T3 (es) 2016-02-29
EP3067057B1 (en) 2022-11-09
PL1931363T3 (pl) 2016-06-30
EP1931363A1 (en) 2008-06-18
JP5802235B2 (ja) 2015-10-28
US10286026B2 (en) 2019-05-14
EP2277524A1 (en) 2011-01-26
JP6150353B2 (ja) 2017-06-21
JP2015163643A (ja) 2015-09-10
AU2006296837B2 (en) 2012-12-13
US20170333514A1 (en) 2017-11-23
EP3067057A1 (en) 2016-09-14
US20150359836A1 (en) 2015-12-17
US20120269791A1 (en) 2012-10-25
JP2009509981A (ja) 2009-03-12
ES2561584T3 (es) 2016-02-29
DK1931363T3 (en) 2016-02-22
SI1931363T1 (sl) 2016-02-29
US8900570B2 (en) 2014-12-02
DK3067057T3 (da) 2023-02-13
JP2013136644A (ja) 2013-07-11
WO2007036230A1 (en) 2007-04-05
US20080311097A1 (en) 2008-12-18
CA2622951A1 (en) 2007-04-05
JP2013144712A (ja) 2013-07-25
JP5363811B2 (ja) 2013-12-11
SI2277524T1 (sl) 2016-02-29
US20130209404A1 (en) 2013-08-15
US8846029B2 (en) 2014-09-30
EP1931363B1 (en) 2015-11-18
DK2277524T3 (en) 2016-02-08
US9205114B2 (en) 2015-12-08

Similar Documents

Publication Publication Date Title
SI2277524T1 (sl) Zdravljenje sindroma razdražljivega črevesja z uporabo probiotičnih bakterij in fermentiranih žit kot efektorjev zdravljenja
ZA200710983B (en) Bacterial cellulose-containing formulations and method of producing effective bacterial cellulose-containing formulations
PH12012500300A1 (en) Induction and stabilization of enzymatic activity in microorganisms
PL2561880T3 (pl) Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierające
ZA200900235B (en) Prevention and treatment of otitis media with non-pathogenic bacterial strains
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
GB2445651B (en) Well treatment products and methods of using them
GB0608647D0 (en) Methods of diagnosis and treatment
EP1848798A4 (en) NEW MICROBIAL ENZYMES AND THEIR USE
GB0513096D0 (en) Treatment of microbial infections
ZA200610279B (en) Treatment of bacterial infections
PL2439268T3 (pl) Immobilizowane enzymy i sposoby ich stosowania
GB2442881B (en) Methods for altering gene expression and methods of treatment utilizing same
GB0504657D0 (en) Compositions and methods of treatment
PT1885848E (pt) Conversão microbiana de ácidos de açúcar e meios úteis nesta
AU2005901416A0 (en) Antibiotic and probiotic treatment and packaging
AU2005904259A0 (en) Compositions and methods of treatment
AU2005903854A0 (en) Compositions and methods of treatment
AU2005901939A0 (en) Treatment of Foodstuffs
GB0512568D0 (en) Method of diagnosis and treatment
TWI371281B (en) Use of fermented milk for manufacture of muscle pain inhibitor and muscle pain inhibitor
GB0516085D0 (en) Treatment of viable cells
AU2005901420A0 (en) Diagnosis and treatment of disorders
IL192438A0 (en) Stable enzymatic preparations and methods of use thereof
HK1100327A (en) Treatment of bacterial infections